Clinical Evidence Shows Venetoclax Combo Is Safe and Effective in AML Patients 80 Years of Age and Up.

Published Date: 13 May 2024

The study discovers that the survival rate is similar to that of the VIALE-A trial's younger patients.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Teenagers Frequently Use Delta-8 THC; New Drug-Coated Balloon Treats Blocked Stents.

2.

Even a few mutated cells can significantly impact how blood cancers develop, study finds

3.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

4.

Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.

5.

In Acute Leukemia With Heavily Pretreated Patients, Menin Inhibitor Yields 63 Percent ORR.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot